Enzo Biochem, Inc. (ENZ) NYSE

0.31

-0.0678(-17.77%)

Updated at April 17 04:00PM

Currency In USD

Valuation

Market Cap58.03M
Enterprise Value9.17M
P/E Ratio-1.72
PEG Ratio-0.71
Price/Sales Ratio1.32
Price/Book Ratio0.84
Enterprise/Revenue0.09
Enterprise/EBITDA-0.38

Fiscal Year

Fiscal YearJuly 31, 2024
Most Recent QuarterApril 30, 2025

Profitability

Profit Margin-0.77
Operating Margin-0.39

Management Effectiveness

Return On Assets-0.33
Return On Equity-0.44

Income Statement

Revenue31.91M
Revenue/Share0.52
Gross Profit14.63M
EBITDA-8.35M
Net Income-26.08M
Diluted EPS-0.51

Balance Sheet

Total Cash36.69M
Total Cash/Share0.7
Total Debt3M
Total Debt/Equity0.07
Current Ratio2.84
Book Value Per Share0.83

Price History

52-Week Change-71.21
52-Week High1.27
52-Week Low0.25
Moving Average 50 Days0.43
Moving Average 200 Days0.84

Statistics

Average Volume348,829
Shares Outstanding52.4M
% Held by Institutions25.65

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield14.44
Payout Ratio-0.51
Last Split Factor21:20
Last Split DateOctober 21, 2004